Carlos L. Arteaga, MD, will be presented with the Gianni Bonadonna Breast Cancer Award at the 2009 ASCO Breast Cancer Symposium in San Francisco. Dr. Arteaga, who is a professor of medicine and cancer biology at Vanderbilt University School of Medicine and director of the breast cancer research program of the Vanderbilt-Ingram Cancer Center in Nashville, will deliver the Bonadonna lecture at the symposium.
Tyler Jacks, PhD, is the new president of AACR. Dr. Jacks is the director of the David H. Koch Institute for Integrative Cancer Research, and the Koch Professor of Biology at the Massachusetts Institute of Technology. He also is an investigator at the Howard Hughes Medical Institute in Chevy Chase, Md. In other news, Dr. Jacks has been elected as a member of the U.S. National Academy of Sciences along with five other AACR members: Doug Hanahan, PhD; Rakesh K. Jain, PhD; V. Craig Jordan, OBE, PhD, DSc (bottom left); Douglas R. Lowy, MD; and Harald zur Hausen, DSc, MD.
Ruth O’Regan, MD, has been appointed to the Louisa and Rand Glenn Family Chair in Breast Cancer Research at Atlanta’s Winship Cancer Institute, Emory University. Dr. O’Regan is an associate professor of hematology and medical oncology, and director of the institute’s translational breast cancer research program. She is also codirector of the Jean Sindab Endowment Research Team, which focuses on breast cancer research in African-American women.
The American Society of Pediatric Hematology/Oncology presented its 2009 Distinguished Career Award to Sharon Murphy, MD. Dr. Murphy is scholar-in-residence at the Institute of Medicine in Washington, DC. For more on Dr. Murphy, see “Investing in Future Generations,” March 2009, page 1.
Sir Philip Cohen of Scotland's University of Dundee has been inducted into the U.S. National Academy of Sciences. Sir Philip is the director of the MRC Protein Phosphorylation Unit and the Scottish Institute for Cell Signalling at the university. He is advising a $13.5 million global research program on the ubiquitin proteasome system with life science company Millipore, Canadian institutions, and a number of Scottish universities, and working alongside ITI Life Sciences to study ubiquitins within his new Protein Ubiquitylation Unit at the Scottish Institute for Cell Signaling.